Aromatase expression in low-grade endometrial stromal sarcomas: An immunohistochemical study

Modern Pathology

Volumn 17, Issue 1, 2004, Pages 104-108

  Reich, Olaf ^a   Regauer, Sigrid ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Aromatase; Endometrium; Stromal sarcoma; Treatment

Indexed keywords

AROMATASE; MONOCLONAL ANTIBODY; PEROXIDASE; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; ENDOMETRIUM SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PEROXIDASE ANTIPEROXIDASE COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STROMA CELL; TUMOR CELL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE; AROMATASE INHIBITORS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; SARCOMA, ENDOMETRIAL STROMAL;

EID: 3543142856     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800031     Document Type: Article

References (26)

1. Koss LG, Spiro RH, Brunschwig A. Endometrial stromal sarcoma. Surg Gynecol Obstet 1965;121:531-537.
2. Evans HL. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982;50:2170-2182.
3. Reich O, Regauer S, Urdl W, et al. Expression of estrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000;82:1030-1034.
4. Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 1998;19:593-607.
5. Miller WR, Mullen P, Telford J, et al. Clinical importance of intratumoral aromatase. Breast Cancer Res Treat 1998;49:27-32.
6. Sumitani H, Shozu M, Segawa T, et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 2000;141:3852-3861.
7. Zhang Z, Yamashita H, Toyama T, et al. Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2002;74:47-53.
8. Tseng L, Tseng JK, Mann WJ, et al. Endocrine aspects of human uterine sarcoma: a preliminary study. Am J Obstet Gynecol 1986;155:95-101.
9. Benedet JL, Pocorelli S. Staging Classification and Clinical Practice Guidelines of Gynecologic Cancers. Elsevier: Oxford, 2000.
10. Harada N. Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J Biochem (Tokyo) 1988;103:106-113.
11. Yang S, Fang Z, Suzuki T, et al. Regulation of aromatase P450 expression in endometrioitic and endometrial stroma cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBP/β in endometriosis is associated with overexpression of aromatase. J Clin Endocrinol Metab 2002;87:2336-2345.
12. Balun SE, Yang S, Fang Z, et al. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol 2001;79:19-25.
13. Watanabe K, Sasano H, Harada N, et al. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridisation, and biochemical studies. Am J Pathol 1995;146:491-500.
14. Genazzani AR, Gadducci A, Gambaccini M. Controversial issues in climacteric medicine II: hormone replacement therapy and cancer. Maturitas 2001;40:117-130.
15. Horowitz K, Rutherford T, Schwartz PE. Hormone replacement therapy in women with sarcomas. CME J Gynecol Oncol 1996;1:23-29.
16. Press MF, Scully RE. Endometrial 'sarcomas' complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. Gynecol Oncol 1985;21:135-154.
17. Baggish MS, Woodruff JD. Uterine stromatosis: clinicopathologic features and hormone dependency. Obstet Gynecol 1972;40:487-498.
18. Gloor E, Schneyder P, Cikes M, et al. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 1982;50:1888-1893.
19. Krieger PD, Gusberg SB. Endolymphatic stromal myosis-a grade I endometrial sarcoma. Gynecol Oncol 1973;1:299-313.
20. Chang KL, Crabtree GS, Lim-Tan SK, et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990;14:415-438.
21. Clement BC, Young RH. Tumors and Tumor-like Lesions of the Uterine Corpus and Cervix. Churchill Livingstone: New York, 1993.
22. Styron SL, Burke TW, Linville WK. Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol 1989;35:275-278.
23. Brueggemeier RW. Aromatase, aromatase inhibitors, and breast cancer. Am J Ther 2001;8:333-344.
24. Sasano H, Sato S, Ito K, et al. Effects of aromatase inhibitors on the pathology of human breast, endometrial and ovarian carcinoma. Endocr Relat Cancer 1999;6:197-204.
25. Noble LS, Simpson ER, Johns A, et al. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-179.
26. Spano JP, Soria JC, Kambouchner M, et al. Long term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 2003;20:87-93.